News
GZPHF
2.140
NaN%
--
Guangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
TipRanks · 04/14 08:40
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
TipRanks · 03/20 14:42
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
TipRanks · 03/20 14:41
Guangzhou Baiyunshan Sets March 2026 Board Meeting for 2025 Results
TipRanks · 03/10 09:18
Guangzhou Baiyunshan Announces Vice Chair Resignation and Change of Authorised Representative
TipRanks · 03/06 09:10
Guangzhou Baiyunshan Sets Out Board Lineup and Committee Roles
TipRanks · 03/06 09:09
Guangzhou Baiyunshan Finalises Partnership Agreement for GP Liwan Fund
TipRanks · 12/31/2025 09:12
Baiyunshan Pharma Clears All Resolutions at Third Extraordinary General Meeting of 2025
TipRanks · 12/30/2025 10:41
Baiyunshan Pharma Subsidiary Finalises GP Guangkai Fund Deal, Liwan Fund Agreement Pending
TipRanks · 12/29/2025 11:08
Guangzhou Baiyunshan Subsidiary Secures Approval for New Rabies Vaccine
TipRanks · 12/28/2025 11:38
Baiyunshan Pharma Unit to Commit Nearly RMB200 Million to Two New Venture Funds in Connected Deals
TipRanks · 12/22/2025 12:09
Baiyunshan Renews Connected Transactions Framework With Controlling Shareholder for 2026
TipRanks · 12/22/2025 12:08
Guangzhou Baiyunshan Acquires 100% Equity in Strategic Expansion Move
TipRanks · 12/17/2025 15:08
Guangzhou Baiyunshan Pharmaceutical to Hold 2025 Extraordinary General Meeting
TipRanks · 12/05/2025 09:12
Guangzhou Baiyunshan Plans Asset-Backed Securitization to Boost Liquidity
TipRanks · 12/01/2025 11:11
Guangzhou Baiyunshan’s GP Corp. Engages in Disclosable Transaction with Industrial Securities
TipRanks · 11/28/2025 08:39
Guangzhou Baiyunshan Subsidiary Secures Land Reserve Compensation Agreement
TipRanks · 11/27/2025 11:39
Guangzhou Baiyunshan Reports Strong Q3 2025 Growth
TipRanks · 10/29/2025 04:16
Guangzhou Baiyunshan Reports Strong Q3 2025 Profit Growth Amid Cash Flow Challenges
TipRanks · 10/28/2025 10:42
Guangzhou Baiyunshan Pharmaceutical Enhances Governance with Revised Committee Rules
TipRanks · 10/28/2025 10:40
More
Webull provides a variety of real-time GZPHF stock news. You can receive the latest news about Guangzhou Pharmaceutical Co Lt through multiple platforms. This information may help you make smarter investment decisions.
About GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a China-based company primarily engaged in the business of pharmaceutical and health. The Company operates through four segments. The Great Southern Medicine segment is engaged in the research and development, manufacturing and sales of Chinese and Western patent medicines, chemical active pharmaceutical ingredients, biopharmaceuticals and natural medicines. The Great Health segment is engaged in the production, research and development and sales of beverages, food, health products and other products. The Great Commercial segment is engaged in the wholesale, retail and import and export of pharmaceutical products, medical devices, health products and other products. The Great Medical segment is engaged in the investment in medical services, traditional Chinese medicine health care, modern elderly care and medical device industries. The Company mainly operates its businesses in the domestic and overseas markets.